摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

calphostin A

中文名称
——
中文别名
——
英文名称
calphostin A
英文别名
——
calphostin A化学式
CAS
——
化学式
C44H38O12
mdl
——
分子量
758.779
InChiKey
DTYXTBFGOFPLIJ-FGZHOGPDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.92
  • 重原子数:
    56.0
  • 可旋转键数:
    12.0
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    164.12
  • 氢给体数:
    2.0
  • 氢受体数:
    12.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    calphostin A甲醇sodium methylate 作用下, 以66%的产率得到calphostin D
    参考文献:
    名称:
    复杂天然产物合成中的卡宾配合物:Calphostins 的全合成
    摘要:
    Calphostin A、B、C 和 D (1-4) 于 1989 年从日本大阪发现的真菌 Cladosporium cladosporioides 中分离出来,属于一类天然存在的苝醌。 1,2 Calphostin 被发现是有效的特异性抑制剂蛋白激酶 C (PKC) 并表现出强烈的细胞毒活性,但没有抗真菌或抗生素活性。3 有趣的是,这种生物活性也被发现是光依赖性的,4 尽管具体机制尚未阐明。PKC 代表细胞内信号通路的一个分支,它的过度刺激与从癌症到糖尿病的多种疾病状态有关。 5 作为不受控制的细胞增殖的特定介质,通过它们对蛋白激酶 C 的作用,钙磷蛋白作为抗癌治疗的潜在药物引起了相当大的关注。6 事实上,已经报道了该组中最简单成员的三种全合成。7 然而,这些合成需要从市售材料中进行 20 多个步骤和/或缺乏有效控制轴向手性。此外,迄今为止尚未报道该组中最具生物活性的钙磷蛋白 C 的全合成。我们在此报告了
    DOI:
    10.1021/ja994313+
  • 作为产物:
    描述:
    methyl 2,6,8-trimethoxy-1-hydroxynaphthalene-3-carboxylate 在 palladium on activated charcoal 盐酸manganese(IV) oxideN-溴代丁二酰亚胺(NBS) 、 lithium aluminium tetrahydride 、 正丁基锂四甲基乙二胺偶氮二甲酸二异丙酯氢溴酸氢气氧气三正丁基氢锡四丁基碘化铵三苯基膦 作用下, 以 四氢呋喃甲苯 为溶剂, 反应 4.0h, 生成 calphostin A
    参考文献:
    名称:
    Atropdiastereoselective Total Synthesis of Phleichrome and the Protein Kinase C Inhibitor Calphostin A
    摘要:
    DOI:
    10.1021/ja00098a043
点击查看最新优质反应信息

文献信息

  • Carbene Complexes in the Synthesis of Complex Natural Products:  Total Synthesis of the Calphostins
    作者:Craig A. Merlic、Courtney C. Aldrich、Jennifer Albaneze-Walker、Alan Saghatelian
    DOI:10.1021/ja994313+
    日期:2000.4.1
    of the mixed carbonate linkage. This was formed by reacting the secondary alcohol of the side chain of 16 with phosgene to give the chloroformate ester followed by in situ reaction with 4-acetoxyphenol providing the mixed carbonate 17. Finally, regioselective demethylation with MgI214 followed by chemoselective methanolysis of the acetate in the presence of the benzoate and carbonate linkages provided
    Calphostin A、B、C 和 D (1-4) 于 1989 年从日本大阪发现的真菌 Cladosporium cladosporioides 中分离出来,属于一类天然存在的苝醌。 1,2 Calphostin 被发现是有效的特异性抑制剂蛋白激酶 C (PKC) 并表现出强烈的细胞毒活性,但没有抗真菌或抗生素活性。3 有趣的是,这种生物活性也被发现是光依赖性的,4 尽管具体机制尚未阐明。PKC 代表细胞内信号通路的一个分支,它的过度刺激与从癌症到糖尿病的多种疾病状态有关。 5 作为不受控制的细胞增殖的特定介质,通过它们对蛋白激酶 C 的作用,钙磷蛋白作为抗癌治疗的潜在药物引起了相当大的关注。6 事实上,已经报道了该组中最简单成员的三种全合成。7 然而,这些合成需要从市售材料中进行 20 多个步骤和/或缺乏有效控制轴向手性。此外,迄今为止尚未报道该组中最具生物活性的钙磷蛋白 C 的全合成。我们在此报告了
  • Total syntheses of phleigchrome, calphostin A, and calphostin D. Unusual stereoselective and stereospecific reactions in the synthesis of perylenequinones
    作者:Chris A. Broka
    DOI:10.1016/s0040-4039(00)92105-1
    日期:1991.2
    This report describes the total synthesis of phleichrome, calphostin A and calphostin D - three protein kinase C inhibitory perylenequinones. The present route affords the targets in enantiomerically pure from and represents the first successful approach to this biologicaly important class of metabolites.
    该报告描述了植物色素,钙磷蛋白A和钙磷蛋白D的总合成-三种蛋白激酶C抑制per醌。本途径提供了对映体纯的靶标,并代表了这种重要的代谢产物生物学上的成功方法。
  • Synthesis of Helically Chiral Molecules: Stereoselective Total Synthesis of the Perylenequinones Phleichrome and Calphostin A
    作者:Robert S. Coleman、Eugene B. Grant
    DOI:10.1021/ja00149a012
    日期:1995.11
    The total syntheses of the perylenequinone natural products phleichrome and calphostin A are detailed. The syntheses were based on (1) the de novo construction of regiospecifically oxygenated and selectively protected naphthalene subunits, (2) the enantiospecific introduction of the stereogenic side chains using a chiral (alpha-alkoxyalkyl)-lithium reagent, and (3) a highly atropdiastereoselective Cu(I)-promoted biaryl synthesis for the stereoselective introduction of the helical axis of the calphostins. The total syntheses were achieved in 13 or 14 steps, respectively, with excellent control of absolute stereochemistry.
  • IIDA, TAKAO;KOBAYASHI, EIJI;YOSHIDA, MAYUMI;SANO, HIROSHI, J. ANTIBIOTICS, 42,(1989) N0, C. 1475-1481
    作者:IIDA, TAKAO、KOBAYASHI, EIJI、YOSHIDA, MAYUMI、SANO, HIROSHI
    DOI:——
    日期:——
  • Total Synthesis of the Calphostins:  Application of Fischer Carbene Complexes and Thermodynamic Control of Atropisomers
    作者:Craig A. Merlic、Courtney C. Aldrich、Jennifer Albaneze-Walker、Alan Saghatelian、Jerome Mammen
    DOI:10.1021/jo0014663
    日期:2001.2.1
    perylenequinones. Thermal equilibration to a 3:1 P:M atropisomeric ratio and separation of the perylenequinones followed by side chain desymmetrization and functionalization led to the total synthesis of enantio- and diastereomerically pure calphostin C in only twelve steps from commercially available starting materials. In addition, calphostins A, B, D, and several structural analogues were prepared to evaluate
    据报道有效的蛋白激酶C抑制剂钙磷蛋白A,B,C和D以及各种结构类似物的总合成。利用对映纯菲舍尔卡宾络合物的氨基苯甲酸酯化反应制备五取代的萘胺。优化侧链取代基后,将萘胺转化为邻萘醌,然后使用三氟乙酸和空气进行仿生氧化二聚,得到阻转异构体per醌的1:2 P / M混合物。热平衡至3:1 P:M的对映异构体比例,并分离出ylene醌,然后进行侧链去对称和官能化,仅用十二个步骤就可以从市售起始原料完全合成对映体和非对映体纯钙黄素C。此外,
查看更多

同类化合物

苝-3,10-二酮 竹红菌乙素 痂囊腔菌素A 格孢毒素II 格孢毒素I 抑制剂C 卡弗他丁A 4,9-二羟基-6,7-二(2-羟基丙基)-1,5,8,12-四甲氧基苝-3,10-二酮 1-[3,10-二羟基-12-[2-(4-羟基苯甲酰基)氧基丙基]-2,6,7,11-四甲氧基-4,9-二氧代二萘嵌苯-1-基]丙-2-基4-羟基苯甲酸酯 1-[3,10-二羟基-12-(2-羟基丙基)-2,6,7,11-四甲氧基-4,9-二氧代二萘嵌苯-1-基]丙-2-基苯甲酸酯 (1S,12aR,12bS)-1,2,12a,12b-四氢-1,4,9,12a-四羟基-3,10-苝二酮 Dimethyl 3,10-Dihydro-2,4,6,7,9,11-hexamethoxy-3,10-dioxo-1,12-perylenediacetate Elsinochrome A Alterlosin I 4,10-dihydroxy-5,9-dihydrodinaphtho<2,1-b:1',2'-d>furan-5,9-dione Stemphyltoxin I Acetic acid 6,7,12-triacetoxy-3,10-dihydroxy-4,9-dioxo-4,9-dihydro-perylen-1-yl ester 4,9-Dihydroxy-1,6,7,12-tetramethoxy-perylene-3,10-dione 1,3,4,6,8,15-Hexahydroxy-10,13-bis-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-dibenzo[a,o]perylene-7,16-dione 1,3,4,6,8,15-Hexahydroxy-10-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-13-methyl-dibenzo[a,o]perylene-7,16-dione Acetic acid 4,9,12-triacetoxy-3,10-dioxo-3,10-dihydro-perylen-1-yl ester Cercosporin, pure 2,11-dihydroxy-4,6,7,9-tetramethoxy-1,12-bis-n-propyl-3,10-perylenequinone 7,19-dihydroxy-5-(2-hydroxypropyl)-21-[(2R)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione 2,11-Diamino-perylene-3,10-dione Stemphyltoxin III (3aS)-7,13-dihydroxy-1t,3c,8t,10c-tetramethyl-(3ar,10ac)-1,3,3a,8,10,10a-hexahydro-2,4,9,11-tetraoxa-dibenzo[bc,kl]coronene-6,14-dione [(2S)-1-[3,10-dihydroxy-12-[(2S)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate 2,4,6,7,9,11-hexamethoxy-1,12-bis-propyl-3,10-perylenequinone 6-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]hexane-1-sulfonic acid 1,2,5,6-tetrahydroxy-dibenzo[a,o]perylene-7,16-dione calphostin D Phleichrome calphostin A [6-acetyl-8-(3-acetyl-5,7-diacetyloxy-2-methyl-4-oxo-1H-naphthalen-1-yl)-4-acetyloxy-7-methyl-5-oxo-8H-naphthalen-2-yl] acetate (13S)-12-acetyl-9,13,17-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,16,18(23),20-nonaene-7,19-dione 4,9-Dihydroxy-1,5,6,7,8,12-hexamethylperylene-3,10-dione Carbonic acid, 2-(12-(2-(benzoyloxy)propyl)-3,10-dihydro-4,9-dihydroxy-2,6,7,11-tetramethoxy-3,10-dioxo-1-perylenyl)-1-methylethyl 4-hydroxyphenyl ester (-)-Phleichrome 1,3,4,6,8,15-Hexahydroxy-9,14-diisopropyl-10,13-dimethoxy-dibenzo[a,o]perylene-7,16-dione 1,6-dihydroxydibenzoperylene-7,16-dione 5-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]pentane-1-sulfonic acid 4-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]butane-1-sulfonic acid Cercosporin (12R,13S)-12-acetyl-9,16-dihydroxy-13-[(1S)-1-hydroxyethyl]-5,10,15,20-tetramethoxyhexacyclo[12.8.0.02,11.03,8.04,21.017,22]docosa-1(14),2(11),3(8),4(21),5,9,15,17(22),19-nonaene-7,18-dione 10,13-dimethyl-1,3,4,6-tetrahydroxy-helianthrone 12-Acetyl-16-(butylamino)-9,17-dihydroxy-5,10,21-trimethoxy-13-methylhexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaene-7,19-dione 5,7,11,13,16,18,22,24-Octahydroxy-6,12,17,23-tetramethyloctacyclo[13.11.1.12,10.03,8.04,25.019,27.021,26.014,28]octacosa-3,5,7,10,12,14(28),15(27),16,18,21,23,25-dodecaene-9,20-dione [(2R)-1-[3,10-dihydroxy-12-[(2S)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate [(2S)-1-[3,10-dihydroxy-12-[(2R)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate